| 期刊簡介 | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | Plastic and Reconstructive Surgery-Global Open (According to the latest JCR data, this journal is not indexed in the JCR.) LetPub Score 3.8
50 ratings
Rate
Reputation 4.6 Influence 2.6 Speed 7.0 | ||||||||||||||||
| 期刊簡稱 | PRS-GLOB OPEN | ||||||||||||||||
| ISSN | 2169-7574 | ||||||||||||||||
| h-index | N.A. | ||||||||||||||||
| CiteScore |
| ||||||||||||||||
| 自引率 (2023-2024) | 13.30%自引率趨勢 | ||||||||||||||||
| 掲載範囲 |
| ||||||||||||||||
| 官方網站 | https://journals.lww.com/prsgo/pages/default.aspx | ||||||||||||||||
| 在線稿件提交 | https://www.editorialmanager.com/gox/default.aspx | ||||||||||||||||
| 開放訪問 | Yes | ||||||||||||||||
| 出版商 | Lippincott Williams and Wilkins Ltd. | ||||||||||||||||
| 主題領域 | SURGERY | ||||||||||||||||
| 出版國/地區 | UNITED STATES | ||||||||||||||||
| 發行頻率 | 月刊 | ||||||||||||||||
| 創刊年 | 2013 | ||||||||||||||||
| 每年文章數 | 836每年文章數趨勢 | ||||||||||||||||
| 黃金OA百分比 | 99.25% | ||||||||||||||||
OA Related Info | APC: Yes（ USD2195; ） APC waiver：No Other charges: No Keywords: plastic surgery、reconstructive surgery、aesthetic surgery、cosmetic surgery、case reports Useful LinksAims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review | ||||||||||||||||
| Web of Science 四分位 （ 2023-2024） | WOS Quartile: Q3
| ||||||||||||||||
| 索引 (SCI or SCIE) | |||||||||||||||||
| 鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=2169-7574%5BISSN%5D | ||||||||||||||||
| 平均審稿時間 * | 來自出版商的數據: 來自作者的數據: 10 Weeks | ||||||||||||||||
| 競爭力 * | 來自作者的數據: | ||||||||||||||||
| 參考鏈接 |
| ||||||||||||||||
| *所有的審稿過程指標，如接受率和審稿速度，僅限於用戶提交的稿件。因此，這些指標可能無法準確反映期刊的競爭力或速度。 | |||||||||||||||||
| 首頁 上一頁 1 下一頁 末頁 (頁 | |
| [Plastic and Reconstructive Surgery-Global Open] 的評論 | 撰寫評論 |
| 作者: Zhaos 領域: 医学 審稿時間: 4.0 month(s) 結果: 修改後接受 撰寫評論 |
2025-07-07 20:41:34 評論於 2024.12.17 submit 2025.1.21 first revised 2025.2.6 second revised 2025.3.1 third revised 2025.4.16 accepted Five reviewers, the workload can be submitted to a 3rd to 2nd tier journal, it's a bit of a loss to submit to this one, but as long as it's accepted, it's good.  (0) 讚！ | Zhaos  |
| 作者: Yolandafeifei 領域: 医学 審稿時間: 1.0 month(s) 結果: 修改後接受 撰寫評論 |
2024-07-30 15:00:25 評論於 Most of the submissions were rejected by PRS and resubmitted. They were not accepted by SCI last year, but they are now in Q3 this year. It's a choice made out of helplessness. (0) 讚！ | Yolandafeifei |
| 首頁 上一頁 1 下一頁 末頁 (頁 | |
Contact us